Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis

BACKGROUND: Aspirin has been revealed to probably decrease the risk of cholangiocarcinoma (CCC), which, nevertheless, is of controversy. To this end, a systematic review and meta-analysis was performed to investigate the above-described association. METHODS: We thoroughly searched PubMed, EMBASE, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jianping, Xu, Weiyu, Bian, Jin, Huang, Hanchun, Bai, Yi, Xu, Yiyao, Lu, Xin, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173493/
https://www.ncbi.nlm.nih.gov/pubmed/30323665
http://dx.doi.org/10.2147/CMAR.S173197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173493/
https://www.ncbi.nlm.nih.gov/pubmed/30323665
http://dx.doi.org/10.2147/CMAR.S173197

Ejemplares similares